Skip to main content
RGR
NYSE Manufacturing

Activist Beretta Proposes $44.80/Share Partial Tender Offer for 20.05% of Sturm, Ruger Shares

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Positive
Importance info
9
Price
$42.3
Mkt Cap
$649.571M
52W Low
$28.33
52W High
$48.21
Market data snapshot near publication time

summarizeSummary

Activist investor Beretta Holding S.A. has formally proposed an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co. shares at $44.80 per share, representing a significant premium. The offer is conditional on the Board exempting its poison pill.


check_boxKey Events

  • Proposed Partial Tender Offer

    Beretta Holding S.A. proposes an all-cash partial tender offer to acquire up to an additional 20.05% of Sturm, Ruger's outstanding shares, which would increase their total beneficial ownership to 30%.

  • Premium Offer Price

    The offer price is $44.80 per share, representing a significant premium of approximately 20% to the 60-day average price (VWAP).

  • Conditional on Poison Pill Exemption

    The tender offer is conditional on Sturm, Ruger's Board granting an exemption to its "poison pill" rights plan, which was adopted on October 14, 2025.

  • Escalation of Activist Campaign

    This proposal intensifies the ongoing proxy fight, with Beretta directly challenging the Board's defensive measures and offering a direct value proposition to shareholders, following a Schedule 13D/A filing earlier today.


auto_awesomeAnalysis

This filing marks a significant escalation in the ongoing proxy battle between Sturm, Ruger & Co. and activist investor Beretta Holding S.A. Beretta's proposal of a premium cash tender offer for a substantial portion of outstanding shares (up to 20.05%, bringing their total to 30%) directly challenges the Board's defensive "poison pill" strategy. For shareholders, this presents a concrete opportunity for liquidity at a premium, potentially forcing the Board to reconsider its stance or face increased pressure from investors. The outcome of the Board's decision regarding the poison pill exemption will be critical in determining the next steps in this high-stakes corporate governance conflict.

At the time of this filing, RGR was trading at $42.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $649.6M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RGR - Latest Insights

RGR
Apr 27, 2026, 8:59 AM EDT
Filing Type: DEFC14A
Importance Score:
9
RGR
Apr 21, 2026, 5:00 PM EDT
Filing Type: PRRN14A
Importance Score:
9
RGR
Apr 15, 2026, 6:38 AM EDT
Filing Type: PRER14A
Importance Score:
9
RGR
Apr 08, 2026, 5:00 PM EDT
Filing Type: DFAN14A
Importance Score:
8
RGR
Apr 07, 2026, 5:06 PM EDT
Filing Type: DFAN14A
Importance Score:
9
RGR
Apr 07, 2026, 5:00 PM EDT
Filing Type: PREC14A
Importance Score:
9
RGR
Apr 06, 2026, 5:20 PM EDT
Filing Type: DFAN14A
Importance Score:
9
RGR
Apr 01, 2026, 5:26 PM EDT
Filing Type: PREC14A
Importance Score:
9
RGR
Mar 31, 2026, 5:18 PM EDT
Filing Type: DFAN14A
Importance Score:
9
RGR
Mar 31, 2026, 9:34 AM EDT
Source: Dow Jones Newswires
Importance Score:
8